The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > ImmuLogic Pharmaceutical Corporation

ImmuLogic Pharmaceutical Corporation
OTC: IMUL
Change
symbol:
     
 PROFILE
ImmuLogic Pharmaceutical thinks it's logical to get out of the drug-development business. The firm, which focused on developing drug-abuse vaccines and allergy treatments, is dissolving. Cantab Pharmaceuticals bought its research on vaccines to combat cocaine and nicotine abuse and addiction. With no products on the market, ImmuLogic relied on grants (including funding from the National Institutes of Health) and funds from collaborative agreements. Its collaborative partners included Schering AG, Hoechst Marion Roussel (now Aventis Pharmaceuticals), and Sankyo Co. The firm will stop trading on August 27, 2002, if it has not fully liquidated its assets by then. Investor Carl Icahn owns about 15% of the company.

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
1998 Sales (mil.): 4.30
1-Yr. Sales Growth: 115.0%
Employees: 5
Revenue per employee: $860,000.00

 KEY PEOPLE
• J. Richard Crowley
    CEO

 CONTACT INFO
12 Alfred St., Ste. 300
Woburn, MA 01801
US
Phone: 781-933-1772
Fax: 781-933-2637

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001